Shares of OpGen, Inc. (NASDAQ:OPGN – Get Free Report) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $1.88 and traded as high as $1.88. OpGen shares last traded at $1.70, with a volume of 6,086 shares changing hands.
Wall Street Analyst Weigh In
Separately, StockNews.com started coverage on shares of OpGen in a research report on Saturday. They set a “sell” rating for the company.
Check Out Our Latest Stock Analysis on OpGen
OpGen Trading Up 10.4 %
OpGen (NASDAQ:OPGN – Get Free Report) last released its quarterly earnings results on Monday, August 19th. The medical research company reported ($1.18) EPS for the quarter. The firm had revenue of $0.03 million during the quarter.
About OpGen
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Further Reading
- Five stocks we like better than OpGen
- Investing in Construction Stocks
- California Resources Stock Could Be a Huge Long-Term Winner
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- P/E Ratio Calculation: How to Assess Stocks
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
